Abstract
There is a plenitude of mechanical and biological valve prostheses available for surgeons’ use. Choice of the optimal valve replacement device may not always be easy, because there does not exist a single valve considered to be the best and most suitable for all patients and situations; however, there always exists a valve that is optimal for a given patient.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
El Oakley R, Kleine P, Bach DS (2008) Choice of prosthetic heart valve in today's practice. Circulation 117:253–256
Vahanian A, Baumgartner H, Bax J et al. (2007) Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28:230–268
Dagenais F, Cartier P, Voisine P et al. (2005) Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? J Thorac Cardiovasc Surg 129:1041–1049
Herijgers P, Verhamme P (2007) Improving the quality of anticoagulant therapy in patients with mechanical heart valves: What are we waiting for? Eur Heart J 28:2424–2426
Colli A, Verhoye JP, Heijmen R et al. (2008). Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results. Eur J Cardiothorac Surg 33:531–536
Colli A, Verhoye JP, Leguerrier A et al. (2007) Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue. Eur J Cardiothorac Surg 31:573–577
Marco F di, Meneghetti G, Gerosa G (2005) Early anticoagulation after aortic valve replacement with bioprostheses: Time to abandon it? J Thorac Cardiovasc Surg 130:1482–1483
Dunning J, Versteegh M, Fabbri A et al. (2008) Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34:73–92
El-Husseiny M, Salhiyyah K, Raja SG et al. (2006) Should warfarin be routinely prescribed for the first three months after a bioprosthetic valve replacement? Interact Cardiovasc Thorac Surg 5:616–623
Gherli T, Colli A, Fragnito C et al. (2004) Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study. Circulation 110:496–500
Goldsmith I, Turpie AG, Lip GY (2002) Valvar heart disease and prosthetic heart valves. Br Med J 325:1228–1231
Nowell J, Wilton E, Markus H et al. (2007) Antithrombotic therapy following bioprosthetic aortic valve replacement. Eur J Cardiothorac Surg 31:578–585
Sundt TM, Zehr KJ, Dearani JA et al. (2005) Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg 129:1024–1031
Vaughan P, Waterworth PD (2005) An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair. J Heart Valve Dis 14:576–582
Schoen FJ, Levy RJ (2005) Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 79:1072–1080
Eichinger WB, Hettich IM, Ruzicka DJ et al. (2008) Twenty-year experience with the St. Jude medical Biocor bioprosthesis in the aortic position. Ann Thorac Surg 86:1204–1210
Aazami M, Schafers HJ (2003) Advances in heart valve surgery. J Interv Cardiol 16:535–541
Jamieson WR, Gudas VM, Burr LH et al. (2009) Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement? Eur J Cardiothorac Surg 35:104–110
Jamieson WR, Koerfer R, Yankah CA et al. (2009) Mitroflow aortic pericardial bioprosthesis: clinical performance. Eur J Cardiothorac Surg 36:818–824
Rahimtoola SH (2003) Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 41:893–904
Takkenberg JJ, Klieverik LM, Bekkers JA et al. (2007) Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study. Eur J Cardiothorac Surg 31:851–859
Joudinaud TM, Baron F, Raffoul R et al. (2008) Redo aortic root surgery for failure of an aortic homograft is a major technical challenge. Eur J Cardiothorac Surg 33:989–994
Sadowski J, Kapelak B, Bartus K et al. (2003) Reoperation after fresh homograft replacement: 23 years' experience with 655 patients. Eur J Cardiothorac Surg 23:996–1001
Harringer W, Loose R, Guha M et al. (1998) Long-term results of aortic valve replacement with allografts: thirteen years followup. Cor Europaneum 7:29–32
O'Brien MF, Harrocks S, Stafford EG et al. (2001) The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 10:334–444
Brown JM, O'Brien SM, Wu C et al. (2009) Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 137:82–90
Al-Halees Z, Pieters F, Qadoura F et al. (2002) The Ross procedure is the procedure of choice for congenital aortic valve disease. J Thorac Cardiovasc Surg 123:437–442
Brown JW, Ruzmetov M, Shahriari A et al. (2009) Midterm results of Ross aortic valve replacement: a single-institution experience. Ann Thorac Surg 88:601–608
Kouchoukos NT, Masetti P, Nickerson NJ et al. (2004) The Ross procedure: long-term clinical and echocardiographic follow-up. Ann Thorac Surg 78:773–781
Kumar AS, Talwar S, Mohapatra R et al. (2005) Aortic valve replacement with the pulmonary autograft: mid-term results. Ann Thorac Surg 80:488–494
Pasquali SK, Shera D, Wernovsky G et al. (2007) Midterm outcomes and predictors of reintervention after the Ross procedure in infants, children, and young adults. J Thorac Cardiovasc Surg 133:893–899
Blauth C (2003) The Ross procedure in 2003. Cardiac Surgery Today 1:60–67
de Kerchove L, Rubay J, Pasquet A et al. (2009) Ross operation in the adult: long-term outcomes after root replacement and inclusion techniques. Ann Thorac Surg 87:95–102
Elkins RC, Thompson DM, Lane MM et al. (2008) Ross operation: 16-year experience. J Thorac Cardiovasc Surg 136:623–630
Luciani GB, Favaro A, Casali G et al. (2005) Ross operation in the young: a ten-year experience. Ann Thorac Surg 80:2271–2277
Jonas RA (2005) The Ross procedure is not the procedure of choice for the teenager requiring aortic valve replacement. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu:176–180
Sampath Kumar A, Talwar S, Saxena A et al. (2006) Ross procedure in rheumatic aortic valve disease. Eur J Cardiothorac Surg 29:156–161
Bonow RO, Carabello BA, Kanu C et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease); developed in collaboration with the Society of Cardiovascular Anesthesiologists; endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114:e84–e231
Brown ML, Schaff HV, Lahr BD et al. (2008) Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses. J Thorac Cardiovasc Surg 135:878–884
Doss M, Martens S, Wood JP et al. (2003) Performance of stentless versus stented aortic valve bioprostheses in the elderly patient: a prospective randomized trial. Eur J Cardiothorac Surg 23:299–304
Chan V, Jamieson WR, Germann E et al. (2006) Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement. J Thorac Cardiovasc Surg 131:1267–1273
Kulik A, Bedard P, Lam BK et al. (2006) Mechanical versus bioprosthetic valve replacement in middle-aged patients. Eur J Cardiothorac Surg 30:485–491
Logeais Y, Langanay T, Corbineau H et al. (1998) Aortic valve replacement in the elderly: Bioprosthesis or mechanical valve? Ann Thorac Surg 66:S77–S81
Peterseim DS, Cen YY, Cheruvu S et al. (1999) Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients. J Thorac Cardiovasc Surg 117:890–897
Unger F, Rainer WG, Horstkotte D et al. (2000) Standards and concepts in valve surgery. J Cardiovasc Surg (Torino) 41:585–593
Prasongsukarn K, Jamieson WR, Lichtenstein SV (2005) Performance of bioprostheses and mechanical prostheses in age group 61–70 years. J Heart Valve Dis 14:501–511
Ninet J, Tronc F, Robin J et al. (1998) Mechanical versus biological isolated aortic valvular replacement after the age of 70: equivalent long-term results. Eur J Cardiothorac Surg 13:84–89
Bauernschmitt R, Vahl CF, Lange R et al. (1996) Surgical treatment of acute endocarditis of the aortic valve with paravalvular abscess: considerations justifying the use of mechanical replacement devices. Eur J Cardiothorac Surg 10:741–747
Baumgartner FJ, Omari BO, Robertson JM et al. (2000) Annular abscesses in surgical endocarditis: anatomic, clinical, and operative features. Ann Thorac Surg 70:442–447
Gaudino M, Filippo C de, Pennestri F et al. (1997) The use of mechanical prostheses in native aortic valve endocarditis. J Heart Valve Dis 6:79–83
Klieverik LM, Yacoub MH, Edwards S et al. (2009) Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses. Ann Thorac Surg 88:1814–1821
Moon MR, Miller DC, Moore KA et al. (2001) Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg 71:1164–1171
Renzulli A, Carozza A, Romano G et al. (2001) Recurrent infective endocarditis: a multivariate analysis of 21 years of experience. Ann Thorac Surg 72:39–43
David TE, Regesta T, Gavra G et al. (2007) Surgical treatment of paravalvular abscess: long-term results. Eur J Cardiothorac Surg 31:43–48
Siniawski H, Lehmkuhl H, Weng Y et al. (2003) Stentless aortic valves as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess. Ann Thorac Surg 75:803–808
Blais C, Dumesnil JG, Baillot R et al. (2003) Impact of valve prosthesis–patient mismatch on short-term mortality after aortic valve replacement. Circulation 108:983–988
Fuster RG, Montero Argudo JA, Albarova OG et al. (2005) Patient–prosthesis mismatch in aortic valve replacement: Really tolerable? Eur J Cardiothorac Surg 27:441–449
Ruel M, Al-Faleh H, Kulik A et al. (2006) Prosthesis–patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: effect on survival, freedom from heart failure, and left ventricular mass regression. J Thorac Cardiovasc Surg 131:1036–1044
Tasca G, Brunelli F, Cirillo M et al. (2005) Impact of valve prosthesis–patient mismatch on left ventricular mass regression following aortic valve replacement. Ann Thorac Surg 79:505–510
Urso S, Sadaba R, Aldamiz-Echevarria G (2009) Is patient–prosthesis mismatch an independent risk factor for early and mid-term overall mortality in adult patients undergoing aortic valve replacement? Interact Cardiovasc Thorac Surg 9:510–518
David TE (2005) Is prosthesis–patient mismatch a clinically relevant entity? Circulation 111:3186–3187
Dumesnil JG, Pibarot P (2006) Prosthesis–patient mismatch and clinical outcomes: the evidence continues to accumulate. J Thorac Cardiovasc Surg 131:952–955
Pibarot P, Dumesnil JG (2000) Hemodynamic and clinical impact of prosthesis–patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 36:1131–1141
de Vincentiis C, Kunkl AB, Trimarchi S et al. (2008) Aortic valve replacement in octogenarians: Is biologic valve the unique solution? Ann Thorac Surg 85:1296–1301
Vicchio M, Della Corte A, Santo LS de et al. (2008) Tissue versus mechanical prostheses: quality of life in octogenarians. Ann Thorac Surg 85:1290–1295
Al-Lawati AA, Venkitraman M, Al-DelaimeTet al.(2002) Pregnancy and mechanical heart valves replacement: dilemma of anticoagulation. Eur J Cardiothorac Surg 22:223–227
Santo LS de, Romano G, Della Corte A et al. (2005) Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year follow-up. J Thorac Cardiovasc Surg 130:13–19
Chan V, Jamieson WR, Fleisher AG et al. (2006) Valve replacement surgery in end-stage renal failure: mechanical prostheses versus bioprostheses. Ann Thorac Surg 81:857–862
David TE, Armstrong S, Sun Z (1998) The Hancock II bioprosthesis at 12 years. Ann Thorac Surg 66:S95–S98
Guenther T, Noebauer C, Mazzitelli D et al. (2008) Tricuspid valve surgery: a thirty-year assessment of early and late outcome. Eur J Cardiothorac Surg 34:402–409
Kawano H, Oda T, Fukunaga S et al. (2000) Tricuspid valve replacement with the St. Jude Medical valve: 19 years of experience. Eur J Cardiothorac Surg 18:565–569
Kunadian B, Vijayalakshmi K, Balasubramanian S et al. (2007) Should the tricuspid valve be replaced with a mechanical or biological valve? Interact Cardiovasc Thorac Surg 6:551–557
Peterffy A, Szentkiralyi I (2001) Mechanical valves in tricuspid position: cause of thrombosis and prevention. Eur J Cardiothorac Surg 19:735–736
Rizzoli G, Vendramin I, Nesseris G et al. (2004) Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional results. Ann Thorac Surg 77:1607–1614
Birkmeyer NJ, Birkmeyer JD, Tosteson AN et al. (2000) Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis. Ann Thorac Surg 70:1946–1952
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dominik, J., Zacek, P. (2010). Choice of the Optimal Valve for Replacement. In: Heart Valve Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12206-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-12206-4_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12205-7
Online ISBN: 978-3-642-12206-4
eBook Packages: MedicineMedicine (R0)